We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

2 hedge funds and large institutions have $13.2K invested in Nymox Pharmaceutical Corp in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

98% more capital invested

Capital invested by funds: $6.67K → $13.2K (+$6.54K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DDC
DF Dent & Co
Maryland
+$9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DDC
1
DF Dent & Co
Maryland
$9K +$9K +75,000 New
FCFC
2
First Citizens Financial Corp
Iowa
$4.21K – – –

NYMX Hedge Fund Activity: Q3 2024 in Review

2 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2024, worth a combined $13.2K — up 98% from $6.67K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new NYMX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was DF Dent & Co, opening a new position worth an estimated $9K.

  • 2 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2024, up from 1 in Q2 2024.
  • Funds reported $13.2K of Nymox Pharmaceutical Corp stock for Q3 2024, up 98% quarter-over-quarter.
  • 1 fund opened new Nymox Pharmaceutical Corp positions in Q3 2024 and 0 closed out, a net change of +1 holder.
  • The largest Nymox Pharmaceutical Corp buyer in Q3 2024 was DF Dent & Co, an estimated $9K added.

Based on aggregated 13F filings for Q3 2024.